Skip to Main Content

Author Details

Matthew S Zabriskie
University of Utah
2011
23
15
PMIDPaper TitleJournal TitlePublished Year
35306920Spatially resolved transcriptomics for evaluation of intracranial vessels in a rabbit model: Proof of concept.Interv Neuroradiol2023
36847368Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke.J Vis Exp2023
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
34027418SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.Blood Cancer Discov2021
32613180Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease.Animal Model Exp Med2020
31543464Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.Cancer Cell2019
29284681A novel <i>AGGF1-PDGFRb</i> fusion in pediatric T-cell acute lymphoblastic leukemia.Haematologica2018
28819281Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib.Leukemia2017
28465516Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.Leukemia2017
26582647Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia.Leukemia2016
26673800A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer.Clin Cancer Res2016
26648538Age-related mutations and chronic myelomonocytic leukemia.Leukemia2016
25134459Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.Leukemia2015
25912019Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.Exp Hematol2015
25676420Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1.Leukemia2015
25721898A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia.Leukemia2015
25573989shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.Blood2015
25132497BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.Cancer Cell2014
23223358BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.Blood2013
23576564Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.Cancer Res2013
22825216Pushing the limits of targeted therapy in chronic myeloid leukaemia.Nat Rev Cancer2012
21908430The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Blood2011
22169110Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.Cancer Cell2011
  • 1 - 23 of 23

Recommended Authors

Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Career Start Year 2017
Number of shared co-authors 17
Jessica Leonard
Oregon Health & Science University
Career Start Year 2015
Number of shared co-authors 15
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 15
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 4
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 0
Catherine C Smith
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 6
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Elisabeth A Lasater
University of California san francisco
Career Start Year 2008
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Yana Pikman
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 3
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 17
Giovanni Roti
University of Parma
Career Start Year 2003
Number of shared co-authors 1
Oliver Hantschel
Institute of Physiological Chemistry, University of Marburg 35032 Marburg Germany .
Career Start Year 2003
Number of shared co-authors 12
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 7
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 21
Nikolas von Bubnoff
University Hospital of Schleswig-Holstein
Career Start Year 1997
Number of shared co-authors 5
Nathanael S Gray
Harvard Medical School
Career Start Year 1996
Number of shared co-authors 5
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 5
Kathryn Evans
Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine
Career Start Year 1996
Number of shared co-authors 0
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 5
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 4
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 4
Bill H Chang
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 21
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 10
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 23
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 16
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 3
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 9
Neil P Shah
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 12

Collaborators

Thomas O'Hare
Huntsman Cancer Institute, University of Utah
Co-authored papers 19
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 18
Anthony D Pomicter
Huntsman Cancer Institute, University of Utah
Co-authored papers 13
Brian J Druker
Oregon Health & Science University
Co-authored papers 11
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Co-authored papers 10
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 9
Jamshid S Khorashad
Institute of Cancer Research
Co-authored papers 8
Anna Senina
Huntsman Cancer Institute, The University of Utah
Co-authored papers 6
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Co-authored papers 5
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 5
Dongqing Yan
Inner Mongolia University
Co-authored papers 5
Hannah M Redwine
Huntsman Cancer Institute, The University of Utah
Co-authored papers 3
Amber D Bowler
Huntsman Cancer Institute, The University of Utah
Co-authored papers 3
Riccardo Baron
Co-authored papers 3
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Co-authored papers 3
Anca Franzini
University of Utah
Co-authored papers 2
Katherine E Varley
Huntsman Cancer Institute
Co-authored papers 2
Richard D Press
Oregon Health and Science University
Co-authored papers 2
Thoralf Lange
Hospital Weissenfels
Co-authored papers 2
Jonathan M Ahmann
Huntsman Cancer Institute, The University of Utah
Co-authored papers 2
Richard Moriggl
Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
Co-authored papers 2
Diana Resetca
University of Toronto
Co-authored papers 2
Hein Than
Singapore General Hospital
Co-authored papers 2
Monika A Davare
Oregon Health Sciences University
Co-authored papers 1
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Jorge Cortes
Georgia Cancer Center
Co-authored papers 1
Jacob P Wagner
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Release 1.2